Brown Advisory’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Brown Advisory’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,000	Closed	-$2K	–	1185
2016 Q3	$2K	Hold	20,000	–	–	﹤0.01%	1069
2016 Q2	$7K	Hold	20,000	–	–	﹤0.01%	1043
2016 Q1	$8K	Hold	20,000	–	–	﹤0.01%	991
2015 Q4	$8K	Hold	20,000	–	–	﹤0.01%	948
2015 Q3	$11K	Hold	20,000	–	–	﹤0.01%	931
2015 Q2	$11K	Hold	20,000	–	–	﹤0.01%	862
2015 Q1	$16K	Hold	20,000	–	–	﹤0.01%	926
2014 Q4	$16K	Hold	20,000	–	–	﹤0.01%	923
2014 Q3	$20K	Hold	20,000	–	–	﹤0.01%	938
2014 Q2	$17K	Buy	+20,000	New	+$24K	﹤0.01%	941

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Brown Advisory's PVCT Position: Q4 2016 in Review

Brown Advisory sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 20,000 shares — an estimated $2K sold.

Brown Advisory first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $20K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Brown Advisory reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Brown Advisory sold 20,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $2K.
Brown Advisory first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Brown Advisory's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $20K in Q3 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Brown Advisory's 13F filing for Q4 2016, filed 13 Feb 2017.